Medicines, 2021
Shortlist up to four to read them side by side.
1,016 medicine recalls FDA’s Enforcement Report published in 2021, newest first; 18,075 in all since 2012.
FDA’s medicine recalls, as its Enforcement Report classifies them, from June 2012. Lists of FDA’s records can’t be saved for alerts: openFDA asks that its data not be used to alert the public (openFDA); FDA’s own emails do that. Copied Nov 5, 2026.
1,016of 1,016 medicine recallsshown with your filters
The list
- Medicine recall TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 1.5MG/ML IN OIL INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 1.75MG/ML IN OIL INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 1MG/ML #2 IN SESAME OIL INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TESTOSTERONE CYPIONATE 200MG/ANASTROZOLE 1MG/ML IN OIL INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TESTOSTERONE CYPIONATE 200MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TESTOSTERONE CYPIONATE 200MG/ML INJ #2 IN SESAME OIL INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TESTOSTERONE CYPIONATE 20MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TESTOSTERONE CYPIONATE 25MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TESTOSTERONE CYPIONATE 30MG/ML #1 IN ETHYL OLEATE INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TESTOSTERONE CYPIONATE 50MG/ML INJ #1 IN ETHYL OLEATE INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAV 23.3MG/PHENTOL 1MG/PGE-1 12MCG/ML INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 15/PHENTOLAMINE 0.25/PGE-1 6 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 15/PHENTOLAMINE 0.5/PGE-1 5 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 15/PHENTOLAMINE 1/PGE-1 10 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 15/PHENTOLAMINE 2/PGE-1 20 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 17.65/PHENTOLAMINE 0.59/PGE-1 5.9 INJ **T 101** INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 18/PHENTOL 0.6/PGE-1 5.88/ML INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 18/PHENTOL 0.6/PGE-1 6/ML INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 20/PHENTOLAMINE 1/PGE-1 20 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 23.3/PHENTOLAMINE 1/PGE-1 12 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 25/PHENTOLAMINE 3/PGE-1 80 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 25MG/PHENTOLAMINE 1MG/PGE1 25MCG/ML INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 26/PHENTOLAMINE 3/PGE-1 60/ML INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 0.25/PGE-1 6 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 0.5/PGE-1 10 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 0.5/PGE-1 20 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 0.5/PGE-1 30 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 0.5/PGE-1 40 /ML INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1.5/PGE-1 50 INJ **ST 1** INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 12 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 2.5 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 20 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 25 INJ**T 106** INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 30 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 40 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 1/PGE-1 5 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 2/PGE-1 20 INJ **T 104** INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 2/PGE-1 30 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 2/PGE-1 40 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 2/PGE-1 50 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 2/PGE-1 60 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 3/PGE-1 100 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 3/PGE-1 30 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 3/PGE-1 40 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 3/PGE-1 40 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 4/PGE-1 20 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 4/PGE-1 5 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
- Medicine recall TRI-MIX PAPAVERINE 30/PHENTOLAMINE 4/PGE-1 60 INJ INJECTABLE Lack of assurance of sterility Class IIFDA’s classNov 17, 2021in FDA’s Enforcement Report2 statesnamed in where it went PublishedNov 17, 2021ClassClass IIStatusTerminatedWhereDistrict of Columbia and Puerto Rico
Nothing matches all of these.
Remove a filter to see more. Each one is a fact FDA’s record publishes, so a recall can be left out because its record is silent on it.
Source:
FDA, Drug recall enforcement reports. Released Nov 3, 2026. Updated weekly.
Recalls of food, medicines, medical devices, pet food and animal drugs are from the U.S. Food and Drug Administration (FDA). FDA does not endorse Hearth Record. openFDA: “Do not rely on openFDA to make decisions regarding medical care.”
Your shortlist0 of 4
Add one more to compare.